Production (Stage)
BioMarin Pharmaceutical Inc.
BMRN
$58.11
$0.560.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.83% | 22.28% | -24.01% | 16.99% | -2.54% |
| Total Receivables | 11.91% | -15.05% | 12.49% | 8.49% | 0.55% |
| Inventory | 3.42% | 4.52% | -0.36% | 4.01% | 2.78% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -9.92% | 19.07% | 5.51% | -1.75% | 15.49% |
| Total Current Assets | 7.28% | 5.75% | -6.23% | 9.20% | 0.98% |
|
|
|||||
| Total Current Assets | 7.28% | 5.75% | -6.23% | 9.20% | 0.98% |
| Net Property, Plant & Equipment | -4.10% | 3.00% | -0.71% | -0.71% | -4.66% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -24.45% | 25.47% | -1.74% | -5.05% | -14.03% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.17% | -5.51% | -0.33% | 0.56% | 5.53% |
| Total Assets | 2.26% | 2.01% | -3.06% | 2.83% | 0.45% |
|
|
|||||
| Total Accounts Payable | 24.79% | -24.63% | 21.33% | -11.92% | -7.38% |
| Total Accrued Expenses | -16.48% | -5.21% | 30.00% | 3.29% | -16.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -16.70% | -6.03% | -98.41% | 0.52% | 0.05% |
| Total Finance Division Other Current Liabilities | 57.24% | -28.49% | 28.73% | 9.54% | -31.38% |
| Total Other Current Liabilities | 57.24% | -28.49% | 28.73% | 9.54% | -31.38% |
| Total Current Liabilities | 3.50% | -15.18% | -32.95% | -1.89% | -7.57% |
|
|
|||||
| Total Current Liabilities | 3.50% | -15.18% | -32.95% | -1.89% | -7.57% |
| Long-Term Debt | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.92% | -23.49% | 6.82% | 1.72% | 43.44% |
| Total Liabilities | 1.70% | -7.43% | -19.26% | -1.00% | -4.83% |
|
|
|||||
| Common Stock & APIC | -0.13% | 1.08% | 0.76% | 1.38% | 0.14% |
| Retained Earnings | 95.37% | 39.09% | 24.92% | 20.11% | 14.26% |
| Treasury Stock & Other | -84.19% | 813.54% | -146.72% | 218.67% | 67.02% |
| Total Common Equity | 2.39% | 4.52% | 2.40% | 4.19% | 2.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.39% | 4.52% | 2.40% | 4.19% | 2.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.39% | 4.52% | 2.40% | 4.19% | 2.47% |
|
|
|||||